Nanobiotix (NANOB)

Currency in EUR
5.90
-0.09(-1.50%)
Closed·
NANOB Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
NANOB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.866.08
52 wk Range
2.626.25
Key Statistics
Prev. Close
5.9
Open
6.05
Day's Range
5.86-6.08
52 wk Range
2.62-6.25
Volume
59.42K
Average Volume (3m)
156.77K
1-Year Change
36.01%
Book Value / Share
-1.39
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NANOB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.42
Upside
+93.56%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

Nanobiotix News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Nanobiotix Company Profile

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.

Employees
108
Market
France

Compare NANOB to Peers and Sector

Metrics to compare
NANOB
Peers
Sector
Relationship
P/E Ratio
−4.1x−3.0x−0.5x
PEG Ratio
0.120.030.00
Price/Book
−4.3x1.7x2.6x
Price / LTM Sales
−39.3x8.4x3.3x
Upside (Analyst Target)
69.5%185.5%43.5%
Fair Value Upside
Unlock14.0%6.9%Unlock

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.42
(+93.56% Upside)

Earnings

Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NANOB Income Statement

People Also Watch

61.30
ABVX
+2.17%
2.5300
ALCPB
-2.32%
249.30
ESLX
-1.42%
68.00
TEPRF
-0.58%

FAQ

What Stock Exchange Does Nanobiotix Trade On?

Nanobiotix is listed and trades on the Paris Stock Exchange stock exchange.

What Is the Stock Symbol for Nanobiotix?

The stock symbol for Nanobiotix is "NANOB."

What Is the Nanobiotix Market Cap?

As of today, Nanobiotix market cap is 282.73M.

What Is Nanobiotix's Earnings Per Share (TTM)?

The Nanobiotix EPS (TTM) is -1.44.

When Is the Next Nanobiotix Earnings Date?

Nanobiotix will release its next earnings report on 03 Sept 2025.

From a Technical Analysis Perspective, Is NANOB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Nanobiotix Stock Split?

Nanobiotix has split 1 times.

How Many Employees Does Nanobiotix Have?

Nanobiotix has 108 employees.

What is the current trading status of Nanobiotix (NANOB)?

As of 07 Aug 2025, Nanobiotix (NANOB) is trading at a price of 5.90, with a previous close of 5.90. The stock has fluctuated within a day range of 5.86 to 6.08, while its 52-week range spans from 2.62 to 6.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.